This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Nature Biotechnology
natbiotech.nature.com
did:plc:ga5bg4f3ryhcu7ndn4yqefjh
For years, the idea of targeted protein degradation stalled because PROTACs were too large and unstable for clinical use. However, in the beginning of May, @fda.gov approved the use of the first PROTAC for adults with a certain form of metastatic breast cancer go.nature.com/4x3NYt7
2026-06-26T16:36:58.465Z